AMD Announces 10 Billion Investment in Taiwans AI Chip Ecosystem
AI Economy Reshapes American Dream BlueCollar Workers Emerge as Key Winners in ATTs Growth Strategy
Xponential Fitness Names Danielle Porto Parra as President Bolstering Leadership Team
T Rowe Price Group Named Among Top HighYield Stocks for Retirement Income
Stellantis Turnaround Plan Prediction Market Regulation and Ouras IPO Filing Highlight Morning Market Movers
SpaceX Files for IPO Under Ticker SPCX Could Boost Elon Musks Trillionaire Status
STM Q1 2026 Earnings EPS Misses Estimates as Stock Edges Higher
BMBL Q1 2026 Earnings EPS Beat Drives Slight Stock Uptick as User Trends Remain in Focus
FCX Q1 2026 Earnings Strong Earnings Beat Amid Robust Copper Demand
PTON Q1 2026 Earnings EPS Miss Masks Optimism Stock Surges 1023
USAC Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds
PWP Q1 2026 Earnings EPS Misses Estimates by 6931 as Stock Declines
Allspring Global Dividend Opportunity Fund EOD Edges Higher Amid Steady Momentum
Vine Hill Capital Investment Corp II Units VHCPU Holds at 1002 as Trading Remains Quiet
Alkermes ALKS Moves Higher on AboveAverage Volume Testing Key Resistance Zone
BrandywineGLOBAL Global Income Opportunities Fund BWG Edges Higher as Income Demand Persists
Cadrenal Therapeutics CVKD Slides 52 as Support Level Comes into Focus
Microsofts Anthropic Partnership May Unlock 43 Billion Azure Revenue by 2030 HSBC Suggests
Enbridge Inc ENB Q1 2026 Earnings Earnings Beat Expectations on Strong Operational Performance
Shift4 Payments FOUR Slides Slightly as Traders Weigh Resistance Levels
RYTHM Inc RYM Q3 2022 Earnings Deep EPS Miss Reflects Ongoing Operational Challenges
AMT Q1 2026 Earnings Strong EPS Beat Driven by Portfolio Growth and Margin Expansion
CMCT Q3 2024 Earnings Massive EPS Miss Sends Stock Lower
Outlook Therapeutics Q1 2026 Earnings EPS Misses Estimates but Stock Surges 29
INOD Q1 2026 Earnings Massive EPS Beat Drives Investor Skepticism
Recursion Pharmaceuticals Q1 2026 Earnings EPS Beat Amidst Pipeline Development
KURA Q1 2026 Earnings WiderthanExpected Loss Highlights ClinicalStage Biotechs Cash Burn